Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Newlink Genetics Cor (NLNK)

Newlink Genetics Cor (NLNK)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 58,523
  • Shares Outstanding, K 37,276
  • Annual Sales, $ 12,470 K
  • Annual Income, $ -53,600 K
  • 60-Month Beta 1.61
  • Price/Sales 4.78
  • Price/Cash Flow N/A
  • Price/Book 0.56

Analyst Rating / Earnings Estimates

Current Rating
See More
Hold
Based on 1 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/19
See More
  • Average Estimate -0.29
  • Number of Estimates 1
  • High Estimate -0.29
  • Low Estimate -0.29
  • Prior Year -0.47
  • Growth Rate Est. (year over year) +38.30%

Price Performance

See More
Period Period Low Period High Performance
1-Month
1.45 +6.21%
on 06/12/19
1.89 -18.52%
on 05/28/19
-0.35 (-18.52%)
since 05/24/19
3-Month
1.45 +6.21%
on 06/12/19
2.18 -29.36%
on 04/01/19
-0.37 (-19.37%)
since 03/22/19
52-Week
1.28 +20.31%
on 01/24/19
5.13 -69.98%
on 06/26/18
-3.56 (-69.80%)
since 06/22/18

Most Recent Stories

More News
Implied Volatility Surging for NewLink Genetics (NLNK) Stock Options

Investors need to pay close attention to NewLink Genetics (NLNK) stock based on the movements in the options market lately.

NLNK : 1.55 (-1.27%)
NewLink Genetics Reports First Quarter 2019 Financial Results and Provides Clinical Activities Update

NewLink Genetics Corporation (NASDAQ:NLNK) today announced financial results for the first quarter ended March 31, 2019 and provided an update on clinical activities.

NLNK : 1.55 (-1.27%)
NewLink Genetics to Participate in Upcoming Investor and Medical Conferences

NewLink Genetics Corporation (NASDAQ:NLNK) announced today that the company will participate in the following investor and medical conferences:

NLNK : 1.55 (-1.27%)
NewLink Genetics to Host Its First Quarter 2019 Conference Call on May 8, 2019

NewLink Genetics Corporation (NASDAQ:NLNK) today announced it will host its first quarter 2019 conference call and webcast at 4:30 PM ET on Wednesday, May 8, 2019, to discuss its first quarter financial...

NLNK : 1.55 (-1.27%)
Healthcare Companies Search for New Ways to Oppose the Spread of Cancer

Cancer is among one of the leading causes of death in the world since many countries are burdened by the lack of access to adequate healthcare, which results in the high number of deaths. In 2018, the...

CRIS : 1.67 (+2.45%)
CVM : 8.89 (+10.71%)
GERN : 1.52 (+2.70%)
SNETD : 0.3900 (+14.71%)
SNET : 0.0103 (+63.49%)
NLNK : 1.55 (-1.27%)
Market Trends Toward New Normal in Cheniere Energy, CoreSite Realty, CalAmp, NextEra Energy Partners, LP, NewLink Genetics, and Amphastar Pharmaceuticals -- Emerging Consolidated Expectations, Analyst Ratings

In new independent research reports released early this morning, Market Source Research released its latest key findings for all current investors, traders, and shareholders of Cheniere Energy, Inc. (NYSE:LNG),...

LNG : 68.18 (-1.06%)
COR : 117.36 (-0.01%)
NEP : 50.10 (+1.54%)
AMPH : 20.16 (-2.33%)
CAMP : 10.22 (+1.89%)
NLNK : 1.55 (-1.27%)
NewLink Genetics Presents Encouraging Phase 2 Results for NLG207 in Ovarian Cancer at AACR 2019

NewLink Genetics Corporation (NASDAQ:NLNK) today announced results from a Phase 2 study of NLG207, a nanoparticle formulation of the topoisomerase 1 inhibitor camptothecin, conducted in conjunction with...

NLNK : 1.55 (-1.27%)
The Zacks Analyst Blog Highlights: ANI, Kamada, Genomic Health and NewLink

The Zacks Analyst Blog Highlights: ANI, Kamada, Genomic Health and NewLink

GHDX : 53.98 (-1.57%)
ANIP : 76.46 (-0.77%)
KMDA : 5.46 (+0.18%)
NLNK : 1.55 (-1.27%)
4 Small Biotech Stocks Likely to Witness More Upside in 2019

The biotech space is witnessing a rally so far in 2019. Here we discuss four stocks that are likely to witness a continuation of the uptrend going ahead.

GHDX : 53.98 (-1.57%)
VRTX : 180.85 (-1.70%)
ANIP : 76.46 (-0.77%)
KMDA : 5.46 (+0.18%)
AMGN : 185.12 (-1.06%)
BIIB : 235.72 (-1.41%)
NLNK : 1.55 (-1.27%)
NewLink Genetics Announces Clinical Trial Abstract Presentation at AACR Annual Meeting

NewLink Genetics Corporation (NASDAQ:NLNK) today announced that a late-breaking abstract reporting results from a Phase 2 study of NLG207, a nanoparticle formulation of the topoisomerase 1 inhibitor, camptothecin,...

NLNK : 1.55 (-1.27%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 88% Sell with a Strongest short term outlook on maintaining the current direction.

Longer term, the trend strength is Average. Long term indicators fully support a continuation of the trend.

See More Share

Trade NLNK with:

Business Summary

NewLink Genetics Corporation is a biopharmaceutical company which focuses on discovering, developing and commercializing immunotherapeutic products for cancer treatment. Its portfolio also includes biologic and small-molecule immunotherapy products used for the treatment of oncology indications. NewLink...

See More

Key Turning Points

2nd Resistance Point 1.65
1st Resistance Point 1.61
Last Price 1.55
1st Support Level 1.53
2nd Support Level 1.49

See More

52-Week High 5.13
Fibonacci 61.8% 3.66
Fibonacci 50% 3.20
Fibonacci 38.2% 2.75
Last Price 1.55
52-Week Low 1.28

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar